TreeWAS – Variant ID: rs6445035

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H66 Suppurative and unspecified otitis media	0.701	0.299	0.000
H65-H75 Diseases of middle ear and mastoid	0.698	0.302	0.000
H66.9 Otitis media, unspecified	0.697	0.303	0.000
H73 Other disorders of tympanic membrane	0.693	0.307	0.000
H73.8 Other specified disorders of tympanic membrane	0.688	0.312	0.000
H72 Perforation of tympanic membrane	0.640	0.360	0.000
H66.4 Suppurative otitis media, unspecified	0.636	0.364	0.000
H72.8 Other perforations of tympanic membrane	0.603	0.397	0.000
H73.1 Chronic myringitis	0.572	0.428	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.556	0.444	0.000
H70 Mastoiditis and related conditions	0.547	0.453	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.544	0.456	0.000
H66.0 Acute suppurative otitis media	0.541	0.459	0.000
H69 Other disorders of Eustachian tube	0.529	0.471	0.000
H65 Nonsuppurative otitis media	0.511	0.489	0.000
H72.0 Central perforation of tympanic membrane	0.505	0.495	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.500	0.500	0.000
H68 Eustachian salpingitis and obstruction	0.500	0.500	0.000
H67 Otitis media in diseases classified elsewhere	0.500	0.500	0.000
H73.0 Acute myringitis	0.497	0.503	0.000
H72.2 Other marginal perforations of tympanic membrane	0.494	0.506	0.000
H73.9 Disorder of tympanic membrane, unspecified	0.489	0.511	0.000
H71 Cholesteatoma of middle ear	0.466	0.534	0.000
H74 Other disorders of middle ear and mastoid	0.457	0.543	0.000
H70.9 Mastoiditis, unspecified	0.445	0.555	0.000
H72.1 Attic perforation of tympanic membrane	0.438	0.562	0.000
H65.4 Other chronic nonsuppurative otitis media	0.438	0.562	0.000
H69.8 Other specified disorders of Eustachian tube	0.437	0.563	0.000
H65.2 Chronic serous otitis media	0.436	0.564	0.000
H70.8 Other mastoiditis and related conditions	0.392	0.608	0.000
H70.2 Petrositis	0.392	0.608	0.000
H70.0 Acute mastoiditis	0.392	0.608	0.000
H74.0 Tympanosclerosis	0.390	0.610	0.000
H66.3 Other chronic suppurative otitis media	0.388	0.612	0.000
H70.1 Chronic mastoiditis	0.382	0.618	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.382	0.618	0.000
H69.0 Patulous Eustachian tube	0.380	0.620	0.000
H65.0 Acute serous otitis media	0.373	0.627	0.000
H65.1 Other acute nonsuppurative otitis media	0.371	0.628	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.359	0.641	0.000
H67.1 Otitis media in viral diseases classified elsewhere	0.359	0.641	0.000
H67.0 Otitis media in bacterial diseases classified elsewhere	0.359	0.641	0.000
H68.1 Obstruction of Eustachian tube	0.359	0.641	0.000
H68.0 Eustachian salpingitis	0.359	0.641	0.000
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.359	0.641	0.000
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.359	0.641	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.344	0.656	0.000
H69.9 Eustachian tube disorder, unspecified	0.333	0.667	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.331	0.669	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.328	0.672	0.000
H74.9 Disorder of middle ear and mastoid, unspecified	0.297	0.702	0.000
H74.1 Adhesive middle ear disease	0.295	0.705	0.000
H74.2 Discontinuity and dislocation of ear ossicles	0.276	0.724	0.000
Chapter VIII Diseases of the ear and mastoid process	0.212	0.788	0.000
H74.4 Polyp of middle ear	0.182	0.818	0.000
H80-H83 Diseases of inner ear	0.179	0.821	0.000
H81 Disorders of vestibular function	0.166	0.834	0.000
H81.2 Vestibular neuronitis	0.156	0.844	0.000
H81.1 Benign paroxysmal vertigo	0.151	0.849	0.000
H81.8 Other disorders of vestibular function	0.141	0.859	0.000
H60-H62 Diseases of external ear	0.130	0.870	0.000
H82 Vertiginous syndromes in diseases classified elsewhere	0.128	0.871	0.000
H80 Otosclerosis	0.127	0.873	0.000
H81.4 Vertigo of central origin	0.119	0.881	0.000
H81.3 Other peripheral vertigo	0.114	0.886	0.000
H60 Otitis externa	0.103	0.897	0.000
H81.9 Disorder of vestibular function, unspecified	0.101	0.899	0.000
H62 Disorders of external ear in diseases classified elsewhere	0.093	0.907	0.000
H60.8 Other otitis externa	0.092	0.908	0.000
H83 Other diseases of inner ear	0.091	0.909	0.000
H80.8 Other otosclerosis	0.091	0.909	0.000
H80.2 Cochlear otosclerosis	0.091	0.909	0.000
H80.1 Otosclerosis involving oval window, obliterative	0.091	0.909	0.000
H80.0 Otosclerosis involving oval window, nonobliterative	0.091	0.909	0.000
H80.9 Otosclerosis, unspecified	0.090	0.910	0.000
H60.5 Acute otitis externa, non-infective	0.084	0.916	0.000
H90-H95 Other disorders of ear	0.080	0.920	0.000
H65.3 Chronic mucoid otitis media	0.076	0.924	0.000
H60.2 Malignant otitis externa	0.076	0.924	0.000
H60.3 Other infective otitis externa	0.074	0.925	0.000
H60.9 Otitis externa, unspecified	0.072	0.928	0.000
H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified	0.069	0.931	0.000
H62.8 Other disorders of external ear in diseases classified elsewhere	0.067	0.933	0.000
H62.4 Otitis externa in other diseases classified elsewhere	0.067	0.933	0.000
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere	0.067	0.933	0.000
H62.2 Otitis externa in mycoses	0.067	0.933	0.000
H62.1 Otitis externa in viral diseases classified elsewhere	0.067	0.933	0.000
H62.0 Otitis externa in bacterial diseases classified elsewhere	0.067	0.933	0.000
H60.4 Cholesteatoma of external ear	0.066	0.934	0.000
H60.0 Abscess of external ear	0.066	0.934	0.000
H83.3 Noise effects on inner ear	0.066	0.934	0.000
H83.2 Labyrinthine dysfunction	0.066	0.934	0.000
H83.1 Labyrinthine fistula	0.066	0.934	0.000
H83.9 Disease of inner ear, unspecified	0.062	0.938	0.000
H91 Other hearing loss	0.060	0.940	0.000
H83.8 Other specified diseases of inner ear	0.059	0.940	0.000
H95.0 Recurrent cholesteatoma of postmastoidectomy cavity	0.059	0.941	0.000
H94 Other disorders of ear in diseases classified elsewhere	0.058	0.942	0.000
H60.1 Cellulitis of external ear	0.057	0.943	0.000
H95.1 Other disorders following mastoidectomy	0.055	0.945	0.000
H61 Other disorders of external ear	0.051	0.949	0.000
H95.9 Postprocedural disorder of ear and mastoid process, unspecified	0.050	0.950	0.000
H95.8 Other postprocedural disorders of ear and mastoid process	0.050	0.950	0.000
H91.9 Hearing loss, unspecified	0.049	0.951	0.000
H91.3 Deaf mutism, not elsewhere classified	0.048	0.952	0.000
H83.0 Labyrinthitis	0.047	0.953	0.000
H91.0 Ototoxic hearing loss	0.043	0.957	0.000
H93 Other disorders of ear, not elsewhere classified	0.043	0.957	0.000
H91.1 Presbycusis	0.043	0.957	0.000
H94.8 Other specified disorders of ear in diseases classified elsewhere	0.041	0.958	0.000
H94.0 Acoustic neuritis in infectious and parasitic diseases classified elsewhere	0.041	0.958	0.000
H91.2 Sudden idiopathic hearing loss	0.041	0.959	0.000
H61.9 Disorder of external ear, unspecified	0.040	0.960	0.000
H91.8 Other specified hearing loss	0.036	0.964	0.000
N83.2 Other and unspecified ovarian cysts	0.036	0.964	0.000
H92 Otalgia and effusion of ear	0.035	0.964	0.000
H61.8 Other specified disorders of external ear	0.035	0.965	0.000
H61.0 Perichondritis of external ear	0.034	0.966	0.000
H61.1 Non-infective disorders of pinna	0.034	0.966	0.000
H93.3 Disorders of acoustic nerve	0.033	0.967	0.000
H93.9 Disorder of ear, unspecified	0.032	0.967	0.000
H93.2 Other abnormal auditory perceptions	0.031	0.969	0.000
H93.0 Degenerative and vascular disorders of ear	0.031	0.969	0.000
H61.3 Acquired stenosis of external ear canal	0.031	0.969	0.000
H92.2 Otorrhagia	0.028	0.972	0.000
H81.0 Meniere's disease	0.027	0.972	0.000
H93.8 Other specified disorders of ear	0.027	0.973	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.023	0.977	0.000
N21.0 Calculus in bladder	0.021	0.979	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.020	0.980	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.019	0.981	0.000
R16.1 Splenomegaly, not elsewhere classified	0.018	0.982	0.000
H93.1 Tinnitus	0.018	0.982	0.000
N21.8 Other lower urinary tract calculus	0.018	0.982	0.000
H92.0 Otalgia	0.017	0.983	0.000
N21 Calculus of lower urinary tract	0.017	0.983	0.000
T50.4 Drugs affecting uric acid metabolism	0.017	0.983	0.000
R16 Hepatomegaly and splenomegaly, not elsewhere classified	0.017	0.983	0.000
H61.2 Impacted cerumen	0.016	0.984	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.016	0.984	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.015	0.985	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.014	0.986	0.000
T50.8 Diagnostic agents	0.014	0.986	0.000
T50.7 Analeptics and opioid receptor antagonists	0.014	0.986	0.000
T50.5 Appetite depressants	0.014	0.986	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.014	0.986	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.014	0.986	0.000
T50.1 Loop [high-ceiling] diuretics	0.014	0.986	0.000
T50.0 Mineralocorticoids and their antagonists	0.014	0.986	0.000
T42.4 Benzodiazepines	0.014	0.986	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.014	0.986	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.013	0.987	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.013	0.987	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.013	0.987	0.000
H92.1 Otorrhoea	0.013	0.987	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.987	0.013
N21.9 Calculus of lower urinary tract, unspecified	0.012	0.988	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.012	0.988	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.012	0.988	0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.012	0.988	0.000
H90 Conductive and sensorineural hearing loss	0.012	0.988	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.012	0.988	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.011	0.989	0.000
C79.2 Secondary malignant neoplasm of skin	0.000	0.989	0.011
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.011	0.989	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.011	0.989	0.000
C79 Secondary malignant neoplasm of other sites	0.000	0.989	0.011
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.011	0.989	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.011	0.989	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.011	0.989	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.011	0.989	0.000
N21.1 Calculus in urethra	0.011	0.989	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.011	0.989	0.000
H90.0 Conductive hearing loss, bilateral	0.010	0.989	0.000
N83.3 Acquired atrophy of ovary and Fallopian tube	0.011	0.989	0.000
N83.6 Haematosalpinx	0.010	0.989	0.000
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.011	0.989	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.010	0.989	0.000
R16.2 Hepatomegaly with splenomegaly, not elsewhere classified	0.010	0.990	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.010	0.990	0.000
T42.1 Iminostilbenes	0.010	0.990	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.010	0.990	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.010	0.990	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.010	0.990	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.010	0.990	0.000
T46.7 Peripheral vasodilators	0.010	0.990	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.010	0.990	0.000
C90.0 Multiple myeloma	0.000	0.990	0.010
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.010	0.990	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.010	0.990	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.010	0.990	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.010	0.990	0.000
T44.0 Anticholinesterase agents	0.010	0.990	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.010	0.990	0.000
T45.0 Antiallergic and antiemetic drugs	0.010	0.990	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.010	0.990	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.010	0.990	0.000
T42.3 Barbiturates	0.010	0.990	0.000
T42.2 Succinimides and oxazolidinediones	0.010	0.990	0.000
T38.1 Thyroid hormones and substitutes	0.010	0.990	0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified	0.009	0.990	0.000
T45.5 Anticoagulants	0.010	0.990	0.000
T38.9 Other and unspecified hormone antagonists	0.009	0.990	0.000
T38.7 Androgens and anabolic congeners	0.009	0.990	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.009	0.990	0.000
T38.5 Other oestrogens and progestogens	0.009	0.990	0.000
T38.4 Oral contraceptives	0.009	0.990	0.000
T38.2 Antithyroid drugs	0.009	0.990	0.000
T38.0 Glucocorticoids and synthetic analogues	0.009	0.990	0.000
T36 Poisoning by systemic antibiotics	0.009	0.990	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.009	0.990	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.009	0.991	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
Z36 Antenatal screening	0.000	0.991	0.009
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.991	0.009
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.991	0.009
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.991	0.009
N83.7 Haematoma of broad ligament	0.009	0.991	0.000
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.009	0.991	0.000
T42.0 Hydantoin derivatives	0.009	0.991	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.991	0.009
T45.9 Primarily systemic and haematological agent, unspecified	0.009	0.991	0.000
T45.8 Other primarily systemic and haematological agents	0.009	0.991	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.009	0.991	0.000
T45.6 Fibrinolysis-affecting drugs	0.009	0.991	0.000
T45.4 Iron and its compounds	0.009	0.991	0.000
T45.3 Enzymes, not elsewhere classified	0.009	0.991	0.000
T45.2 Vitamins, not elsewhere classified	0.009	0.991	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.991	0.009
T46.1 Calcium-channel blockers	0.009	0.991	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.992	0.008
C79.6 Secondary malignant neoplasm of ovary	0.000	0.992	0.008
I74 Arterial embolism and thrombosis	0.008	0.992	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.008	0.992	0.000
H90.5 Sensorineural hearing loss, unspecified	0.008	0.992	0.000
T40.6 Other and unspecified narcotics	0.008	0.992	0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.008	0.992	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.008	0.992	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.992	0.008
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.008	0.992	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.008	0.992	0.000
T37.5 Antiviral drugs	0.008	0.992	0.000
T37.4 Anthelminthics	0.008	0.992	0.000
T37.3 Other antiprotozoal drugs	0.008	0.992	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.008	0.992	0.000
T37.1 Antimycobacterial drugs	0.008	0.992	0.000
T37.0 Sulphonamides	0.008	0.992	0.000
T41.5 Therapeutic gases	0.008	0.992	0.000
T41.4 Anaesthetic, unspecified	0.008	0.992	0.000
T41.3 Local anaesthetics	0.008	0.992	0.000
T41.2 Other and unspecified general anaesthetics	0.008	0.992	0.000
T41.1 Intravenous anaesthetics	0.008	0.992	0.000
T41.0 Inhaled anaesthetics	0.008	0.992	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.008	0.992	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.008	0.992	0.000
T48.5 Anti-common-cold drugs	0.008	0.992	0.000
T48.4 Expectorants	0.008	0.992	0.000
T48.3 Antitussives	0.008	0.992	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.008	0.992	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.008	0.992	0.000
T48.0 Oxytocic drugs	0.008	0.992	0.000
T49.9 Topical agent, unspecified	0.008	0.992	0.000
T49.8 Other topical agents	0.008	0.992	0.000
T49.7 Dental drugs, topically applied	0.008	0.992	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.008	0.992	0.000
T49.5 Ophthalmological drugs and preparations	0.008	0.992	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.008	0.992	0.000
T49.3 Emollients, demulcents and protectants	0.008	0.992	0.000
T49.2 Local astringents and local detergents	0.008	0.992	0.000
T49.1 Antipruritics	0.008	0.992	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.992	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.992	0.008
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.992	0.008
M54.58 Low back pain (Sacral and sacrococcygeal region)	0.008	0.992	0.000
Z36.8 Other antenatal screening	0.000	0.992	0.008
H90.6 Mixed conductive and sensorineural hearing loss, bilateral	0.008	0.992	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.008	0.992	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.008	0.992	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.992	0.008
Z36.9 Antenatal screening, unspecified	0.000	0.992	0.008
M07.30 Other psoriatic arthropathies (Multiple sites)	0.007	0.993	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.993	0.007
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.007	0.993	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.007	0.993	0.000
T47.7 Emetics	0.007	0.993	0.000
T47.6 Antidiarrhoeal drugs	0.007	0.993	0.000
T47.5 Digestants	0.007	0.993	0.000
T47.4 Other laxatives	0.007	0.993	0.000
T47.3 Saline and osmotic laxatives	0.007	0.993	0.000
T47.2 Stimulant laxatives	0.007	0.993	0.000
T47.0 Histamine H(2)-receptor antagonists	0.007	0.993	0.000
I74.0 Embolism and thrombosis of abdominal aorta	0.007	0.993	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.993	0.007
T36.9 Systemic antibiotic, unspecified	0.007	0.993	0.000
T36.8 Other systemic antibiotics	0.007	0.993	0.000
T36.7 Antifungal antibiotics, systemically used	0.007	0.993	0.000
T36.6 Rifamycins	0.007	0.993	0.000
T36.5 Aminoglycosides	0.007	0.993	0.000
T36.4 Tetracyclines	0.007	0.993	0.000
T36.3 Macrolides	0.007	0.993	0.000
T36.2 Chloramphenicol group	0.007	0.993	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.007	0.993	0.000
T40.4 Other synthetic narcotics	0.007	0.993	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.007	0.993	0.000
T40.8 Lysergide [LSD]	0.007	0.993	0.000
T40.7 Cannabis (derivatives)	0.007	0.993	0.000
T40.5 Cocaine	0.007	0.993	0.000
T40.3 Methadone	0.007	0.993	0.000
T40.1 Heroin	0.007	0.993	0.000
T40.0 Opium	0.007	0.993	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.007	0.993	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.007	0.993	0.000
T43.9 Psychotropic drug, unspecified	0.007	0.993	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.993	0.007
T43.6 Psychostimulants with abuse potential	0.007	0.993	0.000
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.006	0.993	0.000
I74.5 Embolism and thrombosis of iliac artery	0.006	0.994	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.006	0.994	0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side	0.006	0.994	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.006	0.994	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.994	0.006
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.006	0.994	0.000
M07.3 Other psoriatic arthropathies	0.006	0.994	0.000
C90.3 Solitary plasmacytoma	0.000	0.994	0.006
C90.1 Plasma cell leukaemia	0.000	0.994	0.006
M07.39 Other psoriatic arthropathies (Site unspecified)	0.006	0.994	0.000
T36.0 Penicillins	0.005	0.994	0.000
T43.2 Other and unspecified antidepressants	0.006	0.994	0.000
H90.3 Sensorineural hearing loss, bilateral	0.005	0.994	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.994	0.006
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side	0.005	0.994	0.000
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.005	0.995	0.000
I74.8 Embolism and thrombosis of other arteries	0.005	0.995	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.005	0.995	0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.005	0.995	0.000
Y40.8 Other systemic antibiotics	0.005	0.995	0.000
M07.38 Other psoriatic arthropathies (Other)	0.005	0.995	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.005	0.995	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.005	0.995	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.005	0.995	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.005	0.995	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.004	0.995	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.004	0.996	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
C91 Lymphoid leukaemia	0.000	0.996	0.004
Y40 Systemic antibiotics	0.004	0.996	0.000
N83.0 Follicular cyst of ovary	0.004	0.996	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.996	0.004
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
Y40.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
R29.6 Tendency to fall, not elsewhere classified	0.004	0.996	0.000
M35.3 Polymyalgia rheumatica	0.004	0.996	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.996	0.004
K25.9 Unspecified as acute or chronic, without haemorrhage or perforation	0.004	0.996	0.000
Z04.8 Examination and observation for other specified reasons	0.004	0.996	0.000
Y40.3 Macrolides	0.004	0.996	0.000
C81 Hodgkin's disease	0.000	0.996	0.004
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.996	0.004
C91.4 Hairy-cell leukaemia	0.000	0.996	0.004
C81.9 Hodgkin's disease, unspecified	0.000	0.996	0.004
K25.3 Acute without haemorrhage or perforation	0.004	0.996	0.000
M77.91 Enthesopathy, unspecified (Shoulder region)	0.004	0.996	0.000
C91.0 Acute lymphoblastic leukaemia	0.000	0.996	0.003
Y40.7 Antifungal antibiotics, systemically used	0.003	0.996	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.003	0.997	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.000	0.997	0.003
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.997	0.003
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.003	0.997	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
K25.4 Chronic or unspecified with haemorrhage	0.003	0.997	0.000
C91.9 Lymphoid leukaemia, unspecified	0.000	0.997	0.003
H90.2 Conductive hearing loss, unspecified	0.003	0.997	0.001
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
Z41.1 Other plastic surgery for unacceptable cosmetic appearance	0.003	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
K25 Gastric ulcer	0.003	0.997	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.997	0.003
C91.7 Other lymphoid leukaemia	0.000	0.997	0.003
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.997	0.003
C91.5 Adult T-cell leukaemia	0.000	0.997	0.003
C91.3 Prolymphocytic leukaemia	0.000	0.997	0.003
C91.2 Subacute lymphocytic leukaemia	0.000	0.997	0.003
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
C95 Leukaemia of unspecified cell type	0.000	0.997	0.003
C81.1 Nodular sclerosis	0.000	0.997	0.003
C84.4 Peripheral T-cell lymphoma	0.000	0.997	0.003
S06.8 Other intracranial injuries	0.003	0.997	0.000
S06.5 Traumatic subdural haemorrhage	0.003	0.997	0.000
C54.1 Endometrium	0.000	0.997	0.003
Z92.6 Personal history of chemotherapy for neoplastic disease	0.000	0.997	0.003
K61.3 Ischiorectal abscess	0.000	0.997	0.003
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
Y41.0 Sulphonamides	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
S06.00 Concussion (without open intracranial wound)	0.003	0.997	0.000
C81.7 Other Hodgkin's disease	0.000	0.997	0.003
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.997	0.003
C81.3 Lymphocytic depletion	0.000	0.997	0.003
C81.2 Mixed cellularity	0.000	0.997	0.003
C84.5 Other and unspecified T-cell lymphomas	0.000	0.997	0.003
C95.9 Leukaemia, unspecified	0.000	0.997	0.003
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.997	0.003
C94 Other leukaemias of specified cell type	0.000	0.997	0.003
I77.1 Stricture of artery	0.003	0.997	0.000
C93 Monocytic leukaemia	0.000	0.997	0.003
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.003	0.997	0.000
H44.2 Degenerative myopia	0.003	0.997	0.000
L27 Dermatitis due to substances taken internally	0.003	0.997	0.000
O68 Labour and delivery complicated by foetal stress [distress]	0.000	0.997	0.003
S06 Intracranial injury	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.003	0.997	0.000
S06.0 Concussion	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
M07 Psoriatic and enteropathic arthropathies	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.000	0.997	0.003
C86 Other specified types of T/NK-cell lymphoma	0.000	0.997	0.003
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.997	0.003
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.997	0.003
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.997	0.003
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.997	0.003
C84.3 Lymphoepithelioid lymphoma	0.000	0.997	0.003
C84.2 T-zone lymphoma	0.000	0.997	0.003
C84.1 Sezary's diease	0.000	0.997	0.003
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.003	0.997	0.000
C84.0 Mycosis fungoides	0.000	0.997	0.003
N32.0 Bladder-neck obstruction	0.000	0.997	0.003
S42.10 Fracture of scapula (closed)	0.003	0.997	0.000
C67.9 Bladder, unspecified	0.000	0.997	0.003
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.000	0.997	0.003
K25.6 Chronic or unspecified with both haemorrhage and perforation	0.002	0.997	0.000
K25.2 Acute with both haemorrhage and perforation	0.002	0.997	0.000
K25.1 Acute with perforation	0.002	0.997	0.000
K25.0 Acute with haemorrhage	0.003	0.997	0.000
T40.2 Other opioids	0.002	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
C67.8 Overlapping lesion of bladder	0.000	0.997	0.003
C95.7 Other leukaemia of unspecified cell type	0.000	0.997	0.002
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.997	0.002
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.997	0.002
C95.0 Acute leukaemia of unspecified cell type	0.000	0.997	0.002
C88 Malignant immunoproliferative diseases	0.000	0.997	0.002
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
C67.4 Posterior wall of bladder	0.000	0.997	0.003
C67 Malignant neoplasm of bladder	0.000	0.997	0.002
S06.81 Other intracranial injuries (with open intracranial wound)	0.002	0.998	0.000
C67.0 Trigone of bladder	0.000	0.998	0.002
M77.9 Enthesopathy, unspecified	0.002	0.998	0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
B97 Viral agents as the cause of diseases classified to other chapters	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
K25.5 Chronic or unspecified with perforation	0.002	0.998	0.000
L27.2 Dermatitis due to ingested food	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
D14.1 Larynx	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
C94.7 Other specified leukaemias	0.000	0.998	0.002
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.998	0.002
C94.5 Acute myelofibrosis	0.000	0.998	0.002
C94.4 Acute panmyelosis	0.000	0.998	0.002
C94.3 Mast cell leukaemia	0.000	0.998	0.002
C94.2 Acute megakaryoblastic leukaemia	0.000	0.998	0.002
C94.1 Chronic erythraemia	0.000	0.998	0.002
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.998	0.002
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.998	0.002
C96.8 Histiocytic sarcoma	0.000	0.998	0.002
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.998	0.002
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.998	0.002
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.998	0.002
C96.3 True histiocytic lymphoma	0.000	0.998	0.002
C96.2 Malignant mast cell tumour	0.000	0.998	0.002
C96.1 Malignant histiocytosis	0.000	0.998	0.002
C96.0 Letterer-Siwe disease	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations